🇺🇸 FDA
Pipeline program

ET-01

SC2019004

Unknown mab completed

Quick answer

ET-01 for Transfusion Dependent Beta-Thalassaemia is a Unknown program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Transfusion Dependent Beta-Thalassaemia
Phase
Unknown
Modality
mab
Status
completed

Clinical trials